These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25832511)

  • 1. Dimensional psychopharmacology in somatising patients.
    Biondi M; Pasquini M
    Adv Psychosom Med; 2015; 34():24-35. PubMed ID: 25832511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DSM-5: from 'somatoform disorders' to 'somatic symptom and related disorders'].
    van der Feltz-Cornelis CM; van Houdenhove B
    Tijdschr Psychiatr; 2014; 56(3):182-6. PubMed ID: 24643828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Gulf War Syndrome twenty years on].
    Auxéméry Y
    Encephale; 2013 Oct; 39(5):332-8. PubMed ID: 23351934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Classification systems and diagnostic coherence in clinical psychopharmacology].
    Ohayon M; Delorme A; Cournoyer G; Cournoyer J; Morrissette R; Vanier C
    Ann Med Psychol (Paris); 1992; 150(4-5):318-22. PubMed ID: 1343543
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychopharmacotherapy of somatic symptoms disorders.
    Somashekar B; Jainer A; Wuntakal B
    Int Rev Psychiatry; 2013 Feb; 25(1):107-15. PubMed ID: 23383672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-symptom psychopharmacology: between the forest and the trees.
    Bostic JQ; Rho Y
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):289-302. PubMed ID: 16321735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of somatoform disorders in DSM-IV and somatic symptom disorders in proposed DSM-V.
    Ghanizadeh A; Firoozabadi A
    Psychiatr Danub; 2012 Dec; 24(4):353-8. PubMed ID: 23132185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body dysmorphic disorder: causes, characteristics, and clinical treatments.
    Neziroglu F; Cash TF
    Body Image; 2008 Mar; 5(1):1-2. PubMed ID: 18358798
    [No Abstract]   [Full Text] [Related]  

  • 9. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology.
    Van Praag HM; Asnis GM; Kahn RS; Brown SL; Korn M; Friedman JM; Wetzler S
    Ann N Y Acad Sci; 1990; 600():501-10. PubMed ID: 2252329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational psychopharmacology in the treatment of multiple personality disorder.
    Loewenstein RJ
    Psychiatr Clin North Am; 1991 Sep; 14(3):721-40. PubMed ID: 1946032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimensional approaches to psychiatric diagnosis in DSM-5.
    Narrow WE; Kuhl EA
    J Ment Health Policy Econ; 2011 Dec; 14(4):197-200. PubMed ID: 22345361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression, pain, and somatoform disorders.
    Henningsen P; Löwe B
    Curr Opin Psychiatry; 2006 Jan; 19(1):19-24. PubMed ID: 16612174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New guidelines on functional and somatoform disorders].
    Hausteiner-Wiehle C; Schäfert R; Sattel H; Ronel J; Herrmann M; Häuser W; Martin A; Henningsen P
    Psychother Psychosom Med Psychol; 2013 Jan; 63(1):26-31. PubMed ID: 23341111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interface of clinical psychopharmacology and psychopathology.
    Benkert O; Maier W
    Eur Arch Psychiatry Neurol Sci; 1989; 238(5-6):280-4. PubMed ID: 2670575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No functional psychopharmacology without functional psychopathology.
    Van Praag HM
    Acta Psychiatr Scand; 2010 Dec; 122(6):438-9. PubMed ID: 20958273
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoamines and abnormal behaviour. A multi-aminergic perspective.
    van Praag HM; Asnis GM; Kahn RS; Brown SL; Korn M; Friedman JM; Wetzler S
    Br J Psychiatry; 1990 Nov; 157():723-34. PubMed ID: 1980627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments.
    Lieb R; Pfister H; Mastaler M; Wittchen HU
    Acta Psychiatr Scand; 2000 Mar; 101(3):194-208. PubMed ID: 10721868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to the assessment of the treatment effects of somatoform disorders.
    Rief W; Hiller W
    Psychosomatics; 2003; 44(6):492-8. PubMed ID: 14597684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder--comparison with DSM-IV somatoform disorders and additional criteria for consideration.
    Voigt K; Wollburg E; Weinmann N; Herzog A; Meyer B; Langs G; Löwe B
    J Psychosom Res; 2012 Nov; 73(5):345-50. PubMed ID: 23062807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Philosophy of clinical psychopharmacology.
    Aragona M
    Psychiatr Danub; 2013 Mar; 25(1):4-10. PubMed ID: 23470600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.